Home > Financial Ratios > NATCO PHARMA
AD     Remove this Ad

NATCO PHARMA Last 5 Year EV/CE History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/CE(x) 1.572.651.973.003.43

What is the latest EV/CE ratio of NATCO PHARMA ?

The latest EV/CE ratio of NATCO PHARMA is 1.57 based on Mar2025 Consolidated results.
Year EV/CE
Mar20251.57
Mar20242.65
Mar20231.97
Mar20223.00
Mar20213.43

How is EV/CE of NATCO PHARMA Trending?

Years EV/CE % Change
Mar2025 1.57
-40.75
Mar2024 2.65
34.52
Mar2023 1.97
-34.33
Mar2022 3
-12.54
Mar2021 3.43 -

Other Financial Ratios of NATCO PHARMA


Compare EV/CE ratio of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹20,138.9 Cr 9.4% 10.3% 37.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

9.4%

10.3%

37.9%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses